History of myeloid-derived suppressor cells.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24060865.
- Also identified by DOI 10.1038/nrc3581 and PMC identifier 4358792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Medical subject headings
- Cell Biology
- Medical Oncology
- Multipotent Stem Cells
- Myeloid Progenitor Cells
- Neoplasms